Month: November 2016

The Snippet: Weaponized antibodies use new tricks to fight cancer

Posted on

Efforts to develop antibodies that can ferry drugs into cancer cells and minimize damage to healthy tissue are gathering steam. The next generation of these ‘weaponized antibody’ therapies, called antibody–drug conjugates (ADCs), is working its way through clinical trials.

Source: The Snippet: Weaponized antibodies use new tricks to fight cancer

Advertisements

NgAgo gene-editing, claiming to be a better alternative to CRISPR gene editing, falls into a controversy in peer-reviewed papers

Posted on

Six months ago, Chinese researchers reported that an enzyme called NgAgo could be used to edit mammalian genes – and that it might be more accurate and more versatile than the popular CRISPR-Cas9 gene-editing technique. But almost immediately, other scientists complained on internet forums that they could not replicate the experiment.

Source: NgAgo gene-editing, claiming to be a better alternative to CRISPR gene editing, falls into a controversy in peer-reviewed papers

Notizia

Posted on

Novartis Buys Blood Disease Drug Maker for $665mn

US FDA approves Intrarosa to treat dyspareunia

Mayne Pharma Launches Temozolomide Capsules in U.S.

Oxford Genetics Receives Grant to Create Virus Packaging Cell Lines

Source: Notizia

Idiopathic Pulmonary Fibrosis: Recent Scenario

Posted on

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease of unknown etiology, closely associated with interstitial lung disease that shows similar symptoms but with different mode of action. The disease is known so because it primarily involves the interstitium, where scars develop and progress

Source: Idiopathic Pulmonary Fibrosis: Recent Scenario

Discount on DelveInsight’s Reports

Posted on

Hurry Up! Grab the latest discount offer…

year-end-discount-sale-copy

The Snippet : CRISPR gene-editing testing

Posted on

The latest news in the ever evolving universe of CRISPR gene technology is that the editing tool has been used for the first time in humans to cure aggresive lung cancer by a team of Chinese researchers. Read about it :

The Snippet : CRISPR gene-editing tested in a person for the first time

 

Notizia

Posted on

Read about the recent Pharma Updates of the week below :

Notizia